FOUNDER ORIGIN FOUNDER CANADA IRAQ DAVIDERRD ICHINDAWIK ROSSI MARKET VALUATION $5B $8B COMPANY BIO ove Moderna is pioneering Currently a principal r messenger RNA investigator at therapeutics. A Boston Children's log breakthrough platform Hospital and the os addressing undruggable Harvard Stem Cell to targets, it offers a superior Institute, Rossi is the alternative to existing drug scientific HOVER and CLICK modalities for a wide range founder of Moderna over logos to view interactive profiles of disease conditions. Therapeutics.